Ayush ministry orders Patanjali to stop advertising Covid2019 drug

Ayush ministry orders Patanjali to stop advertising Covid2019 drug

The government will examine the medicine launched by the Ayurveda brand.

patanjali

NEW DELHI: The Ayush ministry has asked Patanjali to immediately stop promoting and advertising its Covid2019 drug, Coronil, until such claims have been examined. Yoga guru Baba Ramdev yesterday launched the Ayurvedic medicine for treating Covid2019 patients claiming that it can cure the disease within seven days.

ICMR and Ayush ministry distanced themselves from the announcement of Patanjali’s medicine and said that such advertisements of drugs including Ayurvedic medicines come under the purview of Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. It has asked the brand to provide details of the name and composition of the medicine being claimed for Covid2019 treatment at the earliest.

"Ayush ministry has taken cognisance of news in media about ayurvedic medicines developed for Covid2019 treatment by Patanjali Ayurved Ltd,” said its statement.

The ministry has also asked to provide details for site(s)/hospital(s), where Patanjali conducted its research study for Covid2019 treatment and other details regarding protocol, size of the sample/s, clearance by Institutional Ethics Committee, registration with CTRI and results data of the study.

It has also requested Uttarakhand government’s licensing authority to provide copies of license and product approval details of Patanjali’s Coronil, the Ayurvedic medicine which is being claimed for the treatment of Covid2019.